Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 25.90
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
SHA:688739 Revenue
Liaoning Chengda Biotechnology had revenue of 389.11M CNY in the quarter ending September 30, 2025, a decrease of -7.79%. This brings the company's revenue in the last twelve months to 1.47B, down -14.47% year-over-year. In the year 2024, Liaoning Chengda Biotechnology had annual revenue of 1.68B, down -4.22%.
Revenue (ttm)
1.47B
Revenue Growth
-14.47%
P/S Ratio
7.17
Revenue / Employee
813.19K
Employees
1,788
Market Cap
10.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.68B | -73.86M | -4.22% |
| Dec 31, 2023 | 1.75B | -64.90M | -3.58% |
| Dec 31, 2022 | 1.81B | -273.04M | -13.08% |
| Dec 31, 2021 | 2.09B | 92.47M | 4.63% |
| Dec 31, 2020 | 2.00B | 318.65M | 19.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengzhi | 11.53B |
| Youcare Pharmaceutical Group | 2.55B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.96B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.90B |
| Aurisco Pharmaceutical | 1.62B |
| Vcanbio Cell & Gene Engineering Corp., | 1.47B |
| Chengdu Easton Biopharmaceuticals | 1.33B |
| Bio-Thera Solutions | 845.32M |